AskY Therapeutics, Inc. — Form D
AskY Therapeutics, Inc. of Owings Mills, MD, a company, filed a Form D exempt-offering notice with the SEC on 2023-01-17. The offering totals $500K, of which $280K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2023-01-17
- Form: D
- Accession: 0001209191-23-003389
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $500K
- Amount sold: $280K
- Remaining: $220K
- Minimum investment: $25K
- Investors: 10
- Date of first sale: 2022-12-02
- Security types: debt
- Revenue range: No Revenues
- SEC file number: 021-470804
Issuer
- Name: AskY Therapeutics, Inc.
- CIK: 0001962108
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 12405 Hunters Glen, Owings Mills, MD, 21117
- Phone: (713) 715-6820
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Alexander Krupnick | Director | Houston, TX |
| Alexander Krupnick | Executive Officer | Houston, TX |
| Dan Watkins | Director | Houston, TX |
| Dan Watkins | Executive Officer | Houston, TX |
| John Westwick | Director | Santa Barbara, CA |
Other filings by this issuer (1)
More